These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. M-40403 Metaphore Pharmaceuticals. Di Napoli M; Papa F IDrugs; 2005 Jan; 8(1):67-76. PubMed ID: 15650944 [TBL] [Abstract][Full Text] [Related]
6. Metabolic Diseases Drug Discovery World Summit--SRI conference. 28-29 July 2003 San Diego, CA, USA. Knittel T IDrugs; 2003 Sep; 6(9):845-9. PubMed ID: 14565169 [No Abstract] [Full Text] [Related]
7. Drug repurposing: identify, develop and commercialize new uses for existing or abandoned drugs. Part II. Carley DW IDrugs; 2005 Apr; 8(4):310-3. PubMed ID: 15800805 [No Abstract] [Full Text] [Related]
8. Commentary: contribution of pathology to drug research and development in the next decade. Harleman JH Toxicol Pathol; 1999; 27(4):479-80. PubMed ID: 10485834 [No Abstract] [Full Text] [Related]
9. Drug discovery conference 2008. Small-Molecule Drug Discovery: From Early Stage to the Clinic. Terrett NK IDrugs; 2008 Mar; 11(3):164-8. PubMed ID: 18311648 [No Abstract] [Full Text] [Related]
10. Drug discovery alliances. Jones A; Clifford L Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845 [No Abstract] [Full Text] [Related]
11. Frontiers in GPCR research. Stark H Arch Pharm (Weinheim); 2005 Jun; 338(5-6):207. PubMed ID: 15962349 [No Abstract] [Full Text] [Related]
12. At the flick of a switch: epigenetic drugs. Pray L Chem Biol; 2008 Jul; 15(7):640-1. PubMed ID: 18634998 [No Abstract] [Full Text] [Related]
13. Perspective from the founding editors. Preface. Juliano R; Poste G; Tomlinson E Adv Drug Deliv Rev; 2013 Jan; 65(1):3-4. PubMed ID: 22940253 [No Abstract] [Full Text] [Related]
14. Natural products in drug discovery: present status and perspectives. Molinari G Adv Exp Med Biol; 2009; 655():13-27. PubMed ID: 20047031 [TBL] [Abstract][Full Text] [Related]
15. GSK3 inhibitors: development and therapeutic potential. Cohen P; Goedert M Nat Rev Drug Discov; 2004 Jun; 3(6):479-87. PubMed ID: 15173837 [No Abstract] [Full Text] [Related]
16. The end of the beginning? Nat Rev Drug Discov; 2006 Sep; 5(9):705. PubMed ID: 17001798 [No Abstract] [Full Text] [Related]
17. Lapatinib ditosylate GlaxoSmithKline. Kim TE; Murren JR IDrugs; 2003 Sep; 6(9):886-93. PubMed ID: 12964069 [TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical Technology Conference--12th International Meeting. Problems and problem solving strategies in pharmaceutical formulation and drug delivery. 12-15 September 2004, Istanbul, Turkey. Steckel H IDrugs; 2004 Nov; 7(11):996-9. PubMed ID: 15551172 [No Abstract] [Full Text] [Related]
20. Timely synthetic support for medicinal chemists. Potoski J Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]